← Leaderboards
Anthony Gallagher
Eurofins Panlabs, Inc.
$389,300
Attributed
$389,300
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $342.5K · FY2023–24$500K$375K$250K$125K$0
'23
'24
Funding mix
By agency
NIH$389,300 · 1
By mechanism
N01$389,300 · 1
Top collaborators
No co-investigators on record.
Most similar at Eurofins Panlabs, Inc.
Same institution · by research overlap
- Jacob Bode$2,367,927
- Bryan Koci$3,480,946
- Anthony Gallacher$585,330
- N N$12,000
- David Dean$18,273
Others in their field
Other Rising Stars on “Toxin”
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Taryn Miller · Sri International$4,950,919
- Elizabeth Norton · Tulane University Of Louisiana$4,695,387
- Scott Schaus · Sorrento Therapeutics, Inc.$4,590,862
- Ralf Lenigk · Ge Medical Systems Information Technologies, Inc$4,211,973
- Jon Mirasilas · Sri International$3,433,931
Research focus
ToxinProduct DevelopmentProgramsPropertySafetyScreeningServicesTherapeutic DevelopmentToxicologyBiologicalChemistryCommunicable DiseasesDevelopment PlansDrug KineticsEvaluationInterventional Agent DevelopmentIn VitroIn VivoLeadLead OptimizationManufacturePathogenPre-ClinicalNational Institute Of Allergy And Infectious Disease
Grant awards (4)
Task E13: Lead Optimization Screening Assays for ADMET, Safety Profiling, Rodent Pharmacokinetics and MTD$46,800
N01 · FY2024 · AI · contact PI
Task E13: Development of Interventional Agents for Infectious Diseases$154,250
N01 · FY2023 · AI · contact PI
Task E13: Development of Interventional Agents for Antibiotic Resistance Bacteria$154,250
N01 · FY2023 · AI · contact PI
Task E13: Development of Interventional Agents for Infectious Diseases$34,000
N01 · FY2023 · AI · contact PI